Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and NAC for TB Lung Function Recovery
NCT07136987Phase 3Not yet recruiting
- Sponsor
- Open Source Pharma Foundation
- Start
- Jan 2026
- Primary completion
- Jan 2031
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of metformin, acetylcysteine in Tuberculosis (TB), sponsored by Open Source Pharma Foundation. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
metforminacetylcysteine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT07136987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07136987.